KALA BIO enters $15M at-market offering agreement with H.C. Wainwright

KALA BIO, Inc.

Aggregate market value of shares eligible for sale under ATM prospectus supplement currently $15,000,000.
Sales commission to H.C. Wainwright set at 3.0% of gross sales price.
Company has no obligation to sell any shares under the agreement; either party may suspend offerings.
Subject to terms, Wainwright may sell shares on Nasdaq or in privately negotiated transactions.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

KALA BIO, Inc. entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC (effective 2026-01-08).

Action: entry
Agreement: atm program
Counterparty: H.C. Wainwright & Co., LLC
Effective: 2026-01-08

Exact text from the filing

On January 8, 2026, KALA BIO, Inc. (the “ Company ”), entered into an At The Market Offering Agreement (the “ Sales Agreement ”) with H.C. Wainwright & Co., LLC (“ Wainwright ”)

View on SEC.gov

242 material agreements filed in the last 30 days. Browse all material agreements →

KALA BIO, Inc. filing history →

Source: SEC EDGAR

accession 0001829126-26-000110

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.